SenzaGen: Continued Sales Growth in Q3 - Redeye

Redeye comments on SenzaGen’s Q3 sales update with total sales of SEK9m. We endorse that the company continues to grow and believe in a stronger Q4. The sales update does not render any changes in our estimates, and we reiterate our Base Case of SEK17.

Länk till analysen i sin helhet: https://www.redeye.se/research/859663/senzagen-continued-sales-growth-in-q3?utm_source=finwire&utm_medium=RSS